IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q4 2024 Holdings

Filed 2025-02-10 | 9 holdings | $94.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2025-02-18) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$78.8M9,893,65183.7%
Cognition Therapeutics Inc(CGTX)COM19243B102$4.2M6,000,0004.5%
Aileron Therapeutics Inc(RNTX)COM NEW00887A204$3.9M1,690,7514.1%
Lantern Pharma Inc(LTRN)COM51654W101$3.9M1,207,7094.1%
In8bio IncCOM45674E109$2.2M8,600,0012.4%
Opus Genetics Inc(IRD)ACOM67577R102$1.2M995,2491.3%